Bimodal antibody-titer decline following BNT162b2 mRNA anti-SARS-CoV-2 vaccination in healthcare workers of the INT – IRCCS “Fondazione Pascale” Cancer Center (Naples, Italy)

BACKGROUND: Both SARS-CoV-2 mRNA-based vaccines [BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna)] have shown high efficacy, with very modest side effects in limiting transmission of SARS-CoV-2 and in preventing the severe COVID-19 disease, characterized by a worrying high occupation of intensive...

Descripción completa

Detalles Bibliográficos
Autores principales: Isgrò, Maria Antonietta, Trillò, Giusy, Russo, Luigi, Tornesello, Anna Lucia, Buonaguro, Luigi, Tornesello, Maria Lina, Miscio, Leonardo, Normanno, Nicola, Bianchi, Attilio Antonio Montano, Buonaguro, Franco Maria, Cavalcanti, Ernesta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333344/
https://www.ncbi.nlm.nih.gov/pubmed/35902961
http://dx.doi.org/10.1186/s13027-022-00451-1

Ejemplares similares

Ejemplares similares